SCIENCE: Cancerous Chromosome “Bumper” Repair Depends on More than Mutation in Bladder Cancer
February 17, 2015 · Comments Off
Like a car's bumper, telomeres protect chromosomes. CU Cancer Center study in SCIENCE shows that improper repair can cause cancer.
Study Pinpoints How RhoGDI2 Suppresses Bladder Cancer Metastasis
February 12, 2015 · Comments Off
Discovery that RhoGDI2 blocks action of RhoC to suppress tumors may finally provide a druggable target allowing researchers to manipulate this signaling in a way that reduces tumor metastasis.
CU Cancer Center leader honored
January 16, 2015 · Comments Off
By Chris Casey DENVER — University of Colorado Anschutz Medical Campus leaders including Dan Theodorescu,...
Collaboration Between CU Cancer Center and NantBioScience Targets Ral Protein
September 16, 2014 · Comments Off
Collaboration between CU Cancer Center and NantBioScience will allow Theodorescu and team to work toward drugs that target Ral protein activation, implicated in nearly a third of all cancers.
New Knowledge of Genes Driving Bladder Cancer Points to Targeted Treatments
September 15, 2014 · Comments Off
A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important step toward defining the genetics of bladder cancer, and implies there may be at least two distinct genetic types of the disease.
Panel: Time is now for U.S. to lead in biomedical research
September 9, 2014 · Comments Off
The United States is in danger of losing its biomedical edge to countries that are...
Allen Lichter, CEO of ASCO, Says Big Data, Cost/Value and “-Omics” Will Dominate Oncology in 2030
September 4, 2014 · Comments Off
At the CU Cancer Center Fall Retreat 2014, Allen S. Lichter, MD, FASCO, CEO of ASCO, points the way toward the future of oncology in 2030
National Clinical Trial Tests Power of COXEN Model to Predict Best Treatment for Bladder Cancer
August 13, 2014 · Comments Off
COXEN, a computer model that suggests treatment based on cancer genetics, is being tested in a new clinical trial, here at the CU Cancer Center and nationally via clinical sites of the Southwest Oncology Research Group.
“Treatments Waiting to be Discovered” Inside New Database
August 5, 2014 · Comments Off
University of Colorado Cancer Center database, multiMiR, allows researchers to search microRNA, gene, disease, and drug interactions.
amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer research colorado Cancer Survivorship clinical trial colon cancer colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu enzalutamide fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
How I did on Twitter this week: 25 New Followers, 17 Mentions, 13.9K Mention Reach. How'd your week go? via sumall.com/myweek
Remember! "Cancer: The Emperor of All Maladies" starts tonight at 8. You will not want to miss this! ow.ly/KZ956